A Combination of Whey Protein and Vitamin D Reduces Sarcopenia in Patients with Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial.

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.

Patients with chronic obstructive pulmonary disease (COPD) experience an accelerated decline in muscle strength, mass, and functional capacity, known as sarcopenia.

The effects and relevant mechanisms of supplementing whey protein and vitamin D (whey-D) on sarcopenia are unclear.

Who Took Part

By PubMed's age tags, the people studied were middle-aged adults and older adults, both men and women.

Handgrip strength (HGS), gait speed (GS), the short physical performance battery (SPPB), and plasma levels of c-terminal agrin-fragment-22 (CAF22, a marker of neuromuscular junction [NMJ] integrity), and neurofilament light chain (NfL, a marker of neurodegeneration) were measured before and after whey-D supplementation.

How the Study Was Run

In design terms this was a randomized, double-blind and placebo-controlled study.

Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

As a double-blind Vitamin D, K2, Magnesium and Zinc study, the assignments were hidden from both participants and investigators until the end.

A placebo (an inactive look-alike) gave the Vitamin D, K2, Magnesium and Zinc group a baseline to be compared against.

What Was Measured

Topics PubMed links to this paper include Pulmonary Disease, Chronic Obstructive, Sarcopenia, Whey Proteins, Vitamin D, Dietary Supplements, Hand Strength and Muscle Strength.

The authors tagged it with the keywords CAF22, COPD, Neuromuscular junction and Short physical performance battery.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc.

Results are reported in around 7 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2026 (Archives of medical research), a journal based in United States.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.